Marizyme Stock Buy Hold or Sell Recommendation

MRZM Stock  USD 0  0  66.67%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Marizyme is 'Cautious Hold'. The recommendation algorithm takes into account all of Marizyme's available fundamental, technical, and predictive indicators you will find on this site.
  
Check out Marizyme Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
Note, we conduct extensive research on individual companies such as Marizyme and provide practical buy, sell, or hold advice based on investors' constraints. Marizyme. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Execute Marizyme Buy or Sell Advice

The Marizyme recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Marizyme. Macroaxis does not own or have any residual interests in Marizyme or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Marizyme's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell MarizymeBuy Marizyme
Strong Sell

Market Performance

OKDetails

Volatility

Out of controlDetails

Hype Condition

Over hypedDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

Below AverageDetails

Economic Sensitivity

Hyperactively responds to market trendsDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

InapplicableDetails
For the selected time horizon Marizyme has a Mean Deviation of 36.54, Semi Deviation of 15.54, Standard Deviation of 143.03, Variance of 20457.03, Downside Variance of 2270.5 and Semi Variance of 241.49
We provide investment recommendation to complement the last-minute expert consensus on Marizyme. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available at the time. To make sure Marizyme is not overpriced, please verify all Marizyme fundamentals, including its cash per share, as well as the relationship between the earnings per share and net asset . As Marizyme appears to be a penny stock we also strongly suggest to check its price to book numbers.

Marizyme Trading Alerts and Improvement Suggestions

Marizyme is way too risky over 90 days horizon
Marizyme has some characteristics of a very speculative penny stock
Marizyme appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 210.28 K. Net Loss for the year was (11 M) with profit before overhead, payroll, taxes, and interest of 129.93 K.
Marizyme currently holds about 2.04 M in cash with (5.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Marizyme Returns Distribution Density

The distribution of Marizyme's historical returns is an attempt to chart the uncertainty of Marizyme's future price movements. The chart of the probability distribution of Marizyme daily returns describes the distribution of returns around its average expected value. We use Marizyme price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Marizyme returns is essential to provide solid investment advice for Marizyme.
Mean Return
14.69
Value At Risk
-33.33
Potential Upside
2.13
Standard Deviation
50.15
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Marizyme historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Marizyme Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Marizyme or Software sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Marizyme's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Marizyme pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
17.58
β
Beta against Dow Jones26.57
σ
Overall volatility
127.59
Ir
Information ratio 0.10

Marizyme Volatility Alert

Marizyme is showing large volatility of returns over the selected time horizon. Marizyme is a penny stock. Even though Marizyme may be a good instrument to invest, many penny pink sheets are speculative instruments that are subject to artificial stock promotions. Please make sure you fully understand upside and downside scenarios of investing in Marizyme or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings,sudden promotions and many other similar artificial hype indicators. We also encourage traders to check work history of company executives before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Marizyme instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Marizyme Fundamentals Vs Peers

Comparing Marizyme's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Marizyme's direct or indirect competition across all of the common fundamentals between Marizyme and the related equities. This way, we can detect undervalued stocks with similar characteristics as Marizyme or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Marizyme's fundamental indicators could also be used in its relative valuation, which is a method of valuing Marizyme by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Marizyme to competition
FundamentalsMarizymePeer Average
Return On Equity-0.5-0.31
Return On Asset-0.15-0.14
Operating Margin(180.85) %(5.51) %
Current Valuation17.35 M16.62 B
Shares Outstanding10.13 M571.82 M
Shares Owned By Insiders2.04 %10.09 %
Price To Book0.37 X9.51 X
Price To Sales133.06 X11.42 X
Revenue210.28 K9.43 B
Gross Profit129.93 K27.38 B
EBITDA(10.83 M)3.9 B
Net Income(11 M)570.98 M
Cash And Equivalents2.04 M2.7 B
Cash Per Share0.05 X5.01 X
Total Debt495.32 K5.32 B
Debt To Equity0.07 %48.70 %
Current Ratio1.74 X2.16 X
Book Value Per Share1.00 X1.93 K
Cash Flow From Operations(5.79 M)971.22 M
Earnings Per Share(0.39) X3.12 X
Number Of Employees1118.84 K
Beta0.36-0.15
Market Capitalization5.07 M19.03 B
Total Asset66 M29.47 B
Z Score6.08.72
Net Asset66 M

Marizyme Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Marizyme . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Marizyme Buy or Sell Advice

When is the right time to buy or sell Marizyme? Buying financial instruments such as Marizyme Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Marizyme in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Obamacare Repeal Thematic Idea Now

Obamacare Repeal
Obamacare Repeal Theme
Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal. The Obamacare Repeal theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Obamacare Repeal Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Marizyme Pink Sheet

Marizyme financial ratios help investors to determine whether Marizyme Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Marizyme with respect to the benefits of owning Marizyme security.